Hôpital Cochin, Assistance Publique Hôpitaux de Paris
Paris, 75005, France
NCT Number: NCT03895736
The purpose of this study is to determine whether the blood transcriptome of patients resuscitated after out-of-hospital could be an early predictor of the neurological outcome.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Paris, 75005, France
Assessing the prognosis of the patients resuscitated after out-of-hospital cardiac arrest (OHCA) is still highly challenging. Beyond usual neurological markers, experimental and clinical studies have also shown that blood levels of several cytokines or miRNA could be significantly different after cardiac arrest in subjects prematurely died as compared to survivors with a good neurological recovery. Here the investigators propose to investigate a screening approach assessing simultaneously multiple targets of the post-cardiac arrest syndrome through analysis of the whole transcriptome of patients after OHCA. For this purpose, the investigators will collect blood samples from 60 patients after admission at hospital and then 1 and 3 days later. The Pittsburgh Cerebral Performance Category of each patient will be evaluated for each patient at day 60 after cardiac arrest. At the end of the collection period, the blood samples will be prepared for whole genome analysis and RNA sequencing. The primary analysis of the investigators will be the comparison of the transcriptome at day 0 after cardiac arrest in patients reaching Cerebral Performance Category (CPC) 1 at day 60 as compared to all other patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Sampling of 15 ml of blood during a blood test at Day 0, Day 1 and Day 3
Other names: Blood sampling at Day 0, Day 1 and Day 3
Time frame: Day 0
Blood samples will be collected for each patient early after admission at hospital and blood whole transcriptome will be assessed by RNA sequencing
Time frame: Day 60
Pittsburgh Cerebral Performance Category will be evaluated for each patient at day 60
Time frame: Day 1
Blood samples will be collected for each patient at day 1 and blood whole transcriptome will be assessed by RNA sequencing
Time frame: Day 3
Blood samples will be collected for each patient at day 3 and blood whole transcriptome will be assessed by RNA sequencing
Time frame: day 28
Pittsburgh Cerebral Performance Category will be evaluated for each patient at day 28
Time frame: day 28
Time frame: day 60
Assistance Publique - Hôpitaux de Paris
Other
" Etude du Transcriptome Complet Lors du Syndrome Post-arrêt Cardiaque " Transcriptome Assessment After Cardiac Arrest
Acronym: OMECARD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06776302
Cardiac Arrest (CA), Cardiovascular Diseases
Maribor, Slovenia
View Trial DetailsNCT06836908
Cardiac Arrest, Cardiovascular Diseases
Vienna, Austria
View Trial DetailsNCT05756621
Cardiac Arrest, Cardiovascular Diseases
Brescia, BS, Italy
View Trial DetailsNCT07698340
Cardiac Arrest (CA), Cardiovascular Diseases
Ankara, Turkey (Türkiye)
View Trial Details